Promises, handlers, and chains are foundations of modern JavaScript, but they can be tricky. Here are four common traps to ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

What's next for the stock? We take a look at earnings estimates for some clues. Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for ...

KING OF PRUSSIA, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced that it has ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Includes reviews of Arrow Motors from DealerRater. Want to share your experience with this dealership? They were very helpful in helpful in assisting me on purchasing a new car. Unfortunately ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The 247Sports Transfer Portal includes players who have either announced their intent to enter or have officially entered the NCAA Transfer Portal. Under the college transfer policy, when a ...

The Magnificent Seven represent 34.1% of the S&P 500 as of May 2025, up from 12.3% in 2015. From 2015 to 2024, these seven companies achieved a 697.6% return, outperforming the S&P 500. In 2025 ...